AJP - Heart pressure measurements
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (February 20, 2009). doi:10.1152/ajpheart.00908.2008
This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Figures and Videos
Right arrow All Versions of this Article:
296/5/H1694    most recent
00908.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Banerjee, I.
Right arrow Articles by Baudino, T. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Banerjee, I.
Right arrow Articles by Baudino, T. A
Submitted on August 18, 2008
Revised on February 18, 2009
Accepted on February 18, 2009

IL-6 Loss Causes Ventricular Dysfunction, Fibrosis, Reduced Capillary Density and Dramatically Alters the Cell Populations of the Developing and Adult Heart

Indroneal Banerjee1, John W. Fuseler1, Arti R. Intwala1, and Troy A Baudino1*

1 University of South Carolina School of Medicine

* To whom correspondence should be addressed. E-mail: Troy.Baudino{at}uscmed.sc.edu.

Interleukin-6 (IL-6) is a pleiotropic cytokine responsible for many different processes including the regulation of cell growth, apoptosis, differentiation and survival in various cell types and organs, including the heart. Recent studies have indicated that IL-6 is a critical component in the cell-cell communication between myocytes and cardiac fibroblasts. In this study, we examine the effects of IL-6-deficiency on the cardiac cell populations, cardiac function and interactions between the cells of the heart, specifically cardiac fibroblasts and myocytes. To examine the effects of IL-6-loss on cardiac function, we used the IL-6-/- mouse. IL-6-deficiency caused severe cardiac dilatation, increased accumulation of interstitial collagen and altered expression of the adhesion protein periostin. In addition, flow cytometric analyses demonstrated dramatic alterations in the cardiac cell populations of IL-6-/- mice when compared to wild type littermates. We observed a marked increase in the cardiac fibroblast population in IL-6-/- mice, while a concommitment decrease was observed in the other cardiac cell populations examined. Moreover, we observed increased cell proliferation and apoptosis in the developing IL-6-/- heart. Additionally, we observed a significant decrease in the capillary density of IL-6-/- hearts. In order to elucidate the role of IL-6 in the interactions between cardiac fibroblasts and myocytes, we performed in vitro studies and demonstrated that IL-6-deficiency attenuated activation of the STAT3 pathway and VEGF production. Taken together, these data demonstrate that loss of IL-6 causes cardiac dysfunction by shifting the cardiac cell populations, altering the extracellular matrix, and disrupting critical cell-cell interactions.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.